MERS virus confirmed in Europe for the first time in over a decade, with 19 cases reported globally by the WHO. Two cases in France, involving holidaymakers returning from the Arabian Peninsula, mark a significant health concern for the continent still recovering from the COVID-19 pandemic. The Middle East Respiratory Syndrome (MERS) virus, with a 37% fatality rate, has a history of causing hospital outbreaks, including a 2015 emergency in South Korea that resulted in 38 deaths. The virus is primarily spread through infected dromedary camels, and the recent cases in Europe and North America highlight the ongoing risk of global travel-related transmission. The World Health Organization (WHO) warns that the virus continues to pose a threat in countries where it circulates in camels, with potential spillover into the human population. The French patients, both men in their 70s, were placed under close observation, and health officials responded rapidly with contact tracing and surveillance. The European Centre for Disease Prevention and Control (ECDC) assesses the probability of continued transmission as extremely low, but the WHO cautions that MERS cases may be delayed in detection due to similar symptoms with other respiratory diseases. The organization advises strengthened surveillance and infection control protocols in healthcare settings, as well as avoiding raw camel products and maintaining distance from the animals. With no vaccine or specific treatment available, the global risk is assessed as moderate, and the appearance of MERS in Europe underscores the fragility of the post-COVID recovery. Health authorities are strengthening protective measures as holiday reservations surge to prevent another coronavirus crisis.
